Gene · 338413
Papers2,372
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,372
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dysregulated Amino Acid Sensing Drives Colorectal Cancer Growth and Metabolic Reprogramming Leading to Chemoresistance. | Gastroenterology | 2023 | 36410445 | PubTator, text mining | PubMed |
| Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition. | Cancer Res | 2023 | 36409827 | PubTator, text mining | PubMed |
| JAK-STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States. | Cancer Res | 2023 | 36409824 | PubTator, text mining | PubMed |
| SMG1, a nonsense-mediated mRNA decay (NMD) regulator, as a candidate therapeutic target in multiple myeloma. | Mol Oncol | 2023 | 36400430 | PubTator, text mining | PubMed |
| Restored biosynthetic pathways induced by MSCs serve as rescue mechanism in leukemia cells after L-asparaginase therapy. | Blood Adv | 2023 | 36399517 | PubTator, text mining | PubMed |
| Obesity and metabolic syndrome are associated with short-term endocrine therapy resistance in early ER + breast cancer. | Breast Cancer Res Treat | 2023 | 36396775 | PubTator, text mining | PubMed |
| NNMT-DNMT1 Axis is Essential for Maintaining Cancer Cell Sensitivity to Oxidative Phosphorylation Inhibition. | Adv Sci (Weinh) | 2023 | 36382559 | PubTator, text mining | PubMed |
| Molecular Characterization of Acquired Resistance to KRASG12C-EGFR Inhibition in Colorectal Cancer. | Cancer Discov | 2023 | 36355783 | PubTator, text mining | PubMed |
| CVID-Associated B Cell Activating Factor Receptor Variants Change Receptor Oligomerization, Ligand Binding, and Signaling Responses. | J Clin Immunol | 2023 | 36308663 | PubTator, text mining | PubMed |
| Fyn nanoclustering requires switching to an open conformation and is enhanced by FTLD-Tau biomolecular condensates. | Mol Psychiatry | 2023 | 36258016 | PubTator, text mining | PubMed |
| Differential expression of checkpoint markers in the normoxic and hypoxic microenvironment of glioblastomas. | Brain Pathol | 2023 | 36093941 | PubTator, text mining | PubMed |
| Germline homozygous missense DEPDC5 variants cause severe refractory early-onset epilepsy, macrocephaly and bilateral polymicrogyria. | Hum Mol Genet | 2023 | 36067010 | PubTator, text mining | PubMed |
| Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases. | Gut | 2023 | 35705369 | PubTator, text mining | PubMed |
| Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer. | Gut | 2023 | 35623884 | PubTator, text mining | PubMed |
| Characterization of myelodysplastic syndromes hematopoietic stem and progenitor cells using mass cytometry. | Cytometry B Clin Cytom | 2023 | 35289472 | PubTator, text mining | PubMed |
| Sinusoidal and lymphatic vessel growth is controlled by reciprocal VEGF-C-CDH5 inhibition. | Nat Cardiovasc Res | 2022 | 36910472 | PubTator, text mining | PubMed |
| Manipulation of diacylglycerol and ERK-mediated signaling differentially controls CD8+ T cell responses during chronic viral infection. | Front Immunol | 2022 | 36846018 | PubTator, text mining | PubMed |
| Lactate-related metabolic reprogramming and immune regulation in colorectal cancer. | Front Endocrinol (Lausanne) | 2022 | 36778600 | PubTator, text mining | PubMed |
| Discovery of a potent BTK and IKZF1/3 triple degrader through reversible covalent BTK PROTAC development. | Curr Res Chem Biol | 2022 | 36712232 | PubTator, text mining | PubMed |
| Increased mTOR Signaling and Impaired Autophagic Flux Are Hallmarks of SARS-CoV-2 Infection. | Curr Issues Mol Biol | 2022 | 36661509 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338413/papers?page=15